Catheter News and Research RSS Feed - Catheter News and Research

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.
Promising molecular diagnostic approach to endometriosis

Promising molecular diagnostic approach to endometriosis

Researchers at UC San Francisco have identified patterns of genetic activity that can be used to diagnose endometriosis and its severity, a finding that may offer millions of women an alternative to surgery through a simple noninvasive procedure. [More]
A new formal protocol for emergency treatment of patients with aneurysmal SAH

A new formal protocol for emergency treatment of patients with aneurysmal SAH

Neurosurgeons and neurointerventionalists at Kyungpook National University in the Republic of Korea have developed a formal protocol for delivering emergency treatment to patients with subarachnoid hemorrhage (SAH) from ruptured aneurysms within the first few hours after bleeding occurs. [More]
Qosina launches new Swabbable Pre-Slit Transfer Valve

Qosina launches new Swabbable Pre-Slit Transfer Valve

Qosina is pleased to announce the addition of a new Swabbable Pre-Slit Transfer Valve (80191). [More]
Findings illustrate need to monitor all races of heart failure patients for atrial fibrillation

Findings illustrate need to monitor all races of heart failure patients for atrial fibrillation

Black patients who have been diagnosed with heart failure are no less likely than white patients to get atrial fibrillation (an irregular heartbeat, or arrhythmia), according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, which was presented today at the 2014 Scientific Sessions of the American Heart Association. [More]
Electrical stimulation technology can help SCI patients regain bladder control

Electrical stimulation technology can help SCI patients regain bladder control

When individuals suffer a spinal cord injury, paralysis is only a part of the major impact on quality of life. Often they also lose bladder control, which frequently causes infections that can lead to kidney damage. [More]
Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery. [More]
Stradis Healthcare signs definitive agreement to acquire Medikmark

Stradis Healthcare signs definitive agreement to acquire Medikmark

Stradis Healthcare is pleased to announce that it has entered into a definitive acquisition agreement with Medikmark, a leading provider of healthcare kits based in Waukegan, IL, under which Stradis will acquire all shares of Medikmark. [More]
UCSD engineers propose new single-ventricle heart surgery for children

UCSD engineers propose new single-ventricle heart surgery for children

Engineers at the University of California, San Diego, are proposing a new surgical intervention for children born with a single ventricle in their heart--instead of the usual two. The new approach would potentially reduce the number of surgeries the patients have to undergo in the first six months of life from two to just one. If successful, it would also create a more stable circuit for blood to flow from the heart to the lungs and the rest of the body within the first days and months of life. [More]
Cardio3 BioSciences announces acquisition of CorQuest Medical

Cardio3 BioSciences announces acquisition of CorQuest Medical

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today that it has acquired U.S.-based CorQuest Medical Inc. CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery. [More]
New type of medical imaging technology could diagnose plaques

New type of medical imaging technology could diagnose plaques

Researchers are close to commercializing a new type of medical imaging technology that could diagnose cardiovascular disease by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. [More]
University Medical Center's first atrial fibrillation unit opens in Germany

University Medical Center's first atrial fibrillation unit opens in Germany

Nearly 1.8 million people in Germany suffer from atrial fibrillation. This is the most common and clinically significant form of heart rhythm disorder. Shortness of breath, a sudden sense of dizziness, a feeling of pressure in the chest, and palpitations or thumping of the heart so extreme it can be felt beating rapidly and irregularly - this is how many patients describe their first episode of atrial fibrillation. [More]
Newly developed agent filters out toxins from body in the event of overdose

Newly developed agent filters out toxins from body in the event of overdose

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently. [More]
Epidural and spinal anesthesia safe for relieving pain during childbirth

Epidural and spinal anesthesia safe for relieving pain during childbirth

Women seeking pain relief during childbirth should be comforted to know that epidural and spinal anesthesia are extremely safe, suggests a study of more than 80,000 women that reviewed anesthesia complications during obstetrical care. [More]
Nurse-led initiatives reduce length of stay, improve patient outcomes in Philadelphia hospitals

Nurse-led initiatives reduce length of stay, improve patient outcomes in Philadelphia hospitals

Recent nurse-led initiatives addressing some of critical care's most pressing challenges resulted in shorter average lengths of stay and other positive patient and fiscal outcomes in seven Philadelphia-area hospitals. [More]
Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

The Mount Sinai Hospital is first in the United States to use the first and only FDA-approved, drug-coated balloon to open blocked arteries in the leg. [More]
New technique for treating eye cancer retinoblastoma

New technique for treating eye cancer retinoblastoma

Doctors at Cincinnati Children's Hospital Medical Center have developed a new technique for treating the eye cancer retinoblastoma to improve the odds for preventing eye loss, blindness or death in children with advanced forms of the disease. [More]
Nursing home chain agrees to pay $38M to settle government poor care claims

Nursing home chain agrees to pay $38M to settle government poor care claims

Extendicare, which owns 150 nursing homes in 11 states and denied any wrongdoing, was accused of inappropriate billing and providing inadequate care. [More]
ASI treats first patient using Peregrine System Infusion Catheter

ASI treats first patient using Peregrine System Infusion Catheter

Ablative Solutions, Inc., a privately held company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has treated the first patient in the Peregrine Study. [More]
C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today it has received authorization from Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C-Cure in Switzerland. [More]
New study on global burden of venous thromboembolism

New study on global burden of venous thromboembolism

A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population. [More]